Labeling T Cells to Track Immune Response to Immunotherapy in Glioblastoma

While the advent of immunotherapy has revolutionized cancer treatment, its use in the treatment of glioblastoma (GBM) has been less successful. Most studies using immunotherapy in GBM have been negative and the reasons for this are still being studied. In clinical practice, interpreting response to...

Full description

Bibliographic Details

Published in:	Tomography
Main Authors:	John Y. Rhee, Jack Y. Ghannam, Bryan D. Choi, Elizabeth R. Gerstner
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Subjects:	T cell tagging immunotherapy glioblastoma
Online Access:	https://www.mdpi.com/2379-139X/9/1/22